Research location

Manchester

Greater Manchester, United Kingdom

Published trials89
Site observations162
Linked trials published89
Page2 / 2
Advertisement

Research activity in Manchester

Greater Manchester, United Kingdom

CureCurrent currently publishes aggregate city-level research activity for this location: 89 trials and 162 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Manchester

89 linked trials · page 2 of 2
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung CancerNCT02566993 · 2016-08-30 · 1 site observation
COMPLETED
An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD PatientsNCT02799784 · 2016-07-14 · 1 site observation
COMPLETED
Study of TAS3681 in Metastatic Castration Resistant Prostate CancerNCT02566772 · 2016-03-01 · 1 site observation
COMPLETED
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung CancerNCT02481830 · 2015-09-14 · 1 site observation
COMPLETED
An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLCNCT02409368 · 2015-04-29 · 1 site observation
COMPLETED
AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseNCT02284906 · 2015-02-12 · 1 site observation
TERMINATED
Development and Evaluation of a Self-administered/Assisted Visual Field Screening Tool for GlaucomaNCT02162043 · 2014-11-01 · 1 site observation
COMPLETED
Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)NCT02226042 · 2014-10-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive TherapyNCT02172040 · 2014-06-26 · 1 site observation
COMPLETED
Safety and Efficacy of TAK-385 for Patients With Localized Prostate CancerNCT02135445 · 2014-06-01 · 1 site observation
COMPLETED
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast CancerNCT01992952 · 2014-05-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Visual Feedback With Optical Sensing - A Feasibility StudyNCT02068378 · 2014-04-30 · 1 site observation
COMPLETED
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)NCT02041533 · 2014-03-27 · 1 site observation
COMPLETED
Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetNCT01931566 · 2013-08-01 · 1 site observation
TERMINATED
An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in AsthmaNCT01706198 · 2012-11-01 · 34 site observations
COMPLETED
Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF MutationNCT01514864 · 2012-05-31 · 1 site observation
TERMINATED
A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)NCT01551758 · 2012-03-13 · 34 site observations
COMPLETED
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung CancerNCT01454934 · 2011-12-09 · 1 site observation
COMPLETED
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.NCT01475721 · 2011-11-18 · 1 site observation
COMPLETED
A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different TreatmentsNCT01529112 · 2011-11-01 · 1 site observation
COMPLETED
Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected PatientsNCT01332227 · 2011-10-01 · 1 site observation
COMPLETED
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesNCT01400971 · 2011-07-01 · 1 site observation
COMPLETED
Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) PatientsNCT01288287 · 2011-07-01 · 2 site observations
COMPLETED
A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In VolunteersNCT01364519 · 2011-07-01 · 1 site observation
COMPLETED
Simultaneous CBCT Acquisition During Arc RadiotherapyNCT02123888 · 2011-06-01 · 1 site observation
UNKNOWN
Novel Endpoints in Cough Challenge TestingNCT01566968 · 2011-01-01 · 1 site observation
COMPLETED
MEK Inhibitor and Thoracic Radiotherapy TrialNCT01146756 · 2010-06-04 · 1 site observation
COMPLETED
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With PemetrexedNCT01098266 · 2010-04-12 · 1 site observation
COMPLETED
A Study in Painful Diabetic NeuropathyNCT01089556 · 2010-03-01 · 1 site observation
COMPLETED
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung CancerNCT00850577 · 2009-06-01 · 1 site observation
TERMINATED
Study of Immunotherapy to Treat Advanced Prostate CancerNCT00861614 · 2009-05-01 · 1 site observation
COMPLETED
A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast CancerNCT00370552 · 2007-03-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast CancerNCT00288249 · 2005-12-01 · 1 site observation
COMPLETED
BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose TruvadaNCT00272779 · 2005-11-01 · 1 site observation
COMPLETED
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyNCT00268476 · 2005-07-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Remission and Joint Damage Progression in Early Rheumatoid ArthritisNCT00122382 · 2005-07-01 · 1 site observation
COMPLETED
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF TherapyNCT00124982 · 2005-04-01 · 1 site observation
COMPLETED
Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerNCT00080301 · 2003-09-01 · 1 site observation
COMPLETED
Abatacept With Methotrexate- Phase IIBNCT00162266 · 2000-10-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.